MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 43 filers reported holding MIRATI THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $582,000 | -30.3% | 18,411 | -24.1% | 0.14% | -30.2% |
Q3 2015 | $835,000 | +10.6% | 24,258 | +1.1% | 0.20% | +25.9% |
Q2 2015 | $755,000 | +6.0% | 23,996 | -1.1% | 0.16% | +12.1% |
Q1 2015 | $712,000 | +68.7% | 24,270 | +6.6% | 0.14% | +62.1% |
Q4 2014 | $422,000 | +5.8% | 22,768 | +0.0% | 0.09% | +3.6% |
Q3 2014 | $399,000 | – | 22,767 | – | 0.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |